text
large_stringlengths 63
5.87k
| label
large_stringclasses 2
values | netloc
large_stringlengths 5
48
| url
large_stringlengths 32
1.63k
|
|---|---|---|---|
New York-headquartered sports betting operator Novig is expected to become the latest operator to enter Colorado after securing licence approval from the Colorado Division of Gaming.
|
forward
|
www.gamingintelligence.com
|
https://www.gamingintelligence.com/legal/licensing/181187-novig-approved-to-enter-colorado-sports-betting-market
|
The company's market-leading investment guarantee, with software priced according to the revenue of the given plant, is particularly valuable for greenfield plant construction, which will have a murkier picture of operational costs. This is underpinned by the rest of Rockwell's automation ecosystem, which includes SCADA/HMI software and Programmable Logic Controller (PLC) solution offerings. FactoryTalk Optix, the company's cloud-based SCADA/HMI software, offers an unlimited licensing model, in which manufacturers only pay for the functionality they use, ensuring the software's forward compatibility with new technologies, with integration to new Industrial Internet of Things (IIoT) devices, Artificial Intelligence (AI), and Virtual Reality (VR) built into the design.
|
not-forward
|
www.abiresearch.com
|
https://www.abiresearch.com/market-research/insight/7782623-clean-energy-manufacturing-which-vendors-a
|
Delivery workers pick up goods at a logistics station of online grocery platform by Meituan in Beijing, China November 23, 2022. REUTERS/Tingshu Wang/File Photo Purchase Licensing Rights, opens new tab
|
not-forward
|
www.reuters.com
|
https://www.reuters.com/business/retail-consumer/chinese-food-delivery-giant-meituan-beats-revenue-estimates-2024-08-28/
|
These patent wars are getting entirely out of hand as Apple is now going to ask a jury to award them a $40 licensing fee from Samsung for EACH smartphone and tablet that it sells. Apparently Apple has legalized marijuana for its lawyers to smoke and has not told anybody – there is simply no other explanation for this outlandish licensing fee because of only five patents that Apple claims Samsung has infringed on. This request makes Apple look like fools and even the Apple allies at FOSS Patents believe it to be ridiculous, stating that possibly $10 is the highest figure they have ever seen awarded. Apple says that the solution is simple – Samsung would simply tack on the $40 fee to the selling price of its devices and pass it on to the consumer…as Apple passes that joint around the table.
|
not-forward
|
www.androidheadlines.com
|
https://www.androidheadlines.com/2014/03/apple-wants-samsung-pay-40-per-device-sold-five-patent-violations.html
|
Headquartered in Espoo, Finland, HMD Global Oy is the new home of Nokia phones. HMD designs and markets a range of smartphones and feature phones targeted at a range of consumers and price points. With a commitment to innovation and quality, HMD Global Oy is the exclusive licensee of the Nokia brand for phones & tablets. Nokia is registered trademark of Nokia Corporation
|
not-forward
|
flare.pk
|
https://flare.pk/2017/06/overwhelming-response-nokia-phones-advance-telecom-hopes-market-share
|
ImmunoGen has entered a licensing agreement through which Eli Lilly and Company has obtained exclusive rights for the research, development and marketing of antibody-drug conjugates (ADCs).
|
not-forward
|
www.pharmaceutical-technology.com
|
https://www.pharmaceutical-technology.com/news/immunogen-lilly-adcs-agreement
|
Synopsys is currently leading the industry transformation from monolithic system-on-chips to multi-die systems with a comprehensive and scalable solution for fast heterogeneous integration. Multi-die systems enable early architecture exploration, rapid software development and system validation, efficient die/package co-design, robust and secure die-to-die connectivity and improved manufacturing and reliability. The solution, including electronic design automation tools and intellectual property, is integrated with Ansys' multi-physics analysis technology and developed on Taiwan Semiconductor's 7-nanometer (nm), 5nm and 3nm process technologies with support for TSM's 3DFabric technologies and 3Dblox standard.
|
not-forward
|
finance.yahoo.com
|
https://finance.yahoo.com/amphtml/news/synopsys-snps-ansys-taiwan-semiconductor-141802937.html
|
Inner Spirit Holdings (CSE: ISH ) also entered the Ontario market when its subsidiary, Spirit Leaf, signed an agreement with a lottery winner to open a store in Kingston. Spirit Leaf provided "expert product training" as a part of the deal and assisted with the construction of the store and licensing of its brand and operating standards. The Spirit Leaf deal was completed in collaboration with Newstrike Brands (TSXV: HIP ,OTC Pink:NWKRF), a licensed producer that was acquired by HEXO (NYSEAMERICAN: HEXO ,TSX:HEXO) in March.
|
not-forward
|
investingnews.com
|
https://investingnews.com/daily/cannabis-investing/ontario-second-marijuana-retail-lottery
|
The collaboration with Safran, expected to be formalized by the end of 2025, is backed by a ?61,000 crore (US$7.2 billion) investment, reflecting the high stakes of the program. Safran's offer includes 100% Intellectual Property Rights (IPR) and Transfer of Technology (ToT), addressing India's demand for strategic autonomy under the Atmanirbhar Bharat initiative. Unlike earlier collaborations, where Safran retained partial IPR, this deal ensures India can independently manufacture, modify, and potentially export the engine without restrictions. The engine will incorporate sixth-generation features, such as advanced cooling systems for a lower infrared signature, and is designed to support future upgrades, potentially scaling to 125–145kN for sixth-generation platforms like a successor to the IAF's Sukhoi Su-30MKI.
|
forward
|
idrw.org
|
https://idrw.org/gtre-and-safran-set-ambitious-timeline-for-120kn-engine-to-power-amca-mkii
|
Trident Royalties PLC (AIM:TRR) hailed its most significant quarter to date at the end of 2021 as the number of producing assets within the portfolio increased by 350%, with royalty payments "poised for substantial increase" this year. Adriatic Metals PLC (LSE:ADT1, ASX:ADT, OTCQX:ADMLF) said it is pleased with its achievements in the fourth quarter to 31 December 2021, which saw its flagship Vares Silver Project in Bosnia & Herzegovina securing funding through to production, expected to begin in the second quarter of 2023. Tharisa PLC (LSE:THS, JSE:THA) has signed an agreement for the development of a solar power plant to supply power to its Tharisa Mine in South Africa.
|
forward
|
www.proactiveinvestors.co.uk
|
https://www.proactiveinvestors.co.uk/companies/news/973225/proactive-mining-weekly-glencore-riio-tinto-shanta-gold-973225.html?viewSource=TwitterUK
|
"As an Australian owned and operated company, we are very proud to be building this new industry for Queensland. "We have had a home in this state for over 50 years and it represents a hugely important part of our future. "To date, Santos GLNG has provided $5.1 billion worth of work to Queensland businesses and over the coming decades of operation Santos GLNG will contribute billions of dollars in royalty payments to the people of Queensland." Santos owns 30% of the GLNG joint venture, Petronas owns 27.5%, Total SA owns 27.5% and KOGAS owns 15%.
|
forward
|
www.miningmonthly.com
|
https://www.miningmonthly.com/markets/international-coal-news/1288647/promises-glng-hits-75-completion
|
Ted Baker plc engages in the design, wholesale, and retail of menswear, womenswear, and accessories under the Ted Baker brand in the United States, the United Kingdom, rest of Europe, Canada, and South Africa. The company operates through three segments: Retail, Wholesale, and Licensing. It offers various collections, including childrenswear, suiting, lingerie and nightwear, men's underwear, fragrance, skincare, eyewear, watches, luggage, jewelry and personal technology accessories, bedding, towels, wallpapers, rugs, gifting and stationery, swimwear, footwear, and toiletries. The company distributes its products through retail stores, concessions, retailers, and department stores, as well as through its e-commerce business. It operates through a network of 85 own stores, 130 concessions, and 31 outlets. Ted Baker plc was founded in 1987 and is headquartered in London, the United Kingdom.
|
not-forward
|
www.dailypolitical.com
|
https://www.dailypolitical.com/2025/09/04/ted-baker-otcmktstbakf-columbia-sportswear-nasdaqcolm-financial-comparison.html
|
The deal between Microsoft and Lenovo includes a patent cross-licensing agreement that covers Lenovo and Motorola devices. That means Lenovo can install Microsoft's software on its smartphones without having to cough up a licensing fee. Lenovo acquired the Motorola smartphone business from Google in October 2014. But in a market dominated by Apple and Android, Motorola phones haven't sold as well as the company had hoped. Regardless, millions of Lenovo's Android-based devices are expected to ship over the next several years, the company said.
|
forward
|
www.cnet.com
|
https://www.cnet.com/tech/services-and-software/microsoft-software-to-hop-onto-lenovo-smartphones
|
RELATED: AT&T preps for 5G demo at June conference in Los Angeles area Getting true gigabit throughputs for 5G is going to involve millimeter wave spectrum, and AT&T's acquisition of FiberTower last year was really important because it got a large, nationwide block of 39 GHz spectrum, AT&T Chairman and CEO Randall Stephenson said during a JPMorgan conference on Tuesday, according to a Seeking Alpha transcript. Getting true gigabit speeds also will require a lot of small cell deployments, and the U.S. government can help there in terms of permitting, licensing and helping get municipalities on board. At the end of the day, the difficult part is deploying hundreds of thousands of small cells, and getting permission municipality by municipality is going to be what takes the most time, he said.
|
forward
|
www.fierce-network.com
|
https://www.fierce-network.com/wireless/at-t-gets-ok-to-do-5g-immersive-gaming-demo-at-e3
|
NEW YORK, Dec. 14, 2022 /PRNewswire/ -- Genpact (NYSE: G ), a global professional services firm focused on delivering digital transformation, today announced that it has earned the rank of a Leader in Everest Group's inaugural Digital Platform and Augmentation Suite (DPAS) in Insurance Business Process Services (BPS) PEAK Matrix Assessment 2022. The report examines 15 insurance BPS providers, and evaluates their relative positioning based on service focus, key intellectual property solutions, domain investments, and case studies.
|
not-forward
|
www.prnewswire.com
|
https://www.prnewswire.com/news-releases/genpact-recognized-as-a-leader-in-everest-groups-digital-platform-and-augmented-services-dpas-in-insurance-bps-peak-matrix-assessment-2022-301702523.html
|
[1/5] Ford Motor Co. Flat Rock Assembly Plant is seen in Flat Rock, Michigan, U.S. January 3, 2017. REUTERS/Rebecca Cook Purchase Licensing Rights, opens new tab
|
not-forward
|
www.reuters.com
|
https://www.reuters.com/article/us-usa-trump-autos-idUSKBN14N1T0
|
BERKELEY, Calif., May 18, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today announced it has earned a $10 million milestone payment, reflecting the clinical advancement of an asset the Company licensed to one of its pharmaceutical partners.
|
not-forward
|
globenewswire.com
|
http://globenewswire.com/news-release/2017/05/18/987708/0/en/XOMA-Earns-10-Million-Milestone-Payment-as-Another-of-its-Licensed-Assets-Advances-into-Clinical-Development.html
|
In Latin America, sales were up +4.7% on a like-for-like basis, with volume/mix up +1.2% and price up +3.5%. In EDP, the growth was still impacted by the licensing out of milk business in Brazil, while Danone, Danette and YoPro brands delivered a robust performance. Specialized Nutrition delivered strong growth, led by Aptamil, while Waters benefited from normalized weather conditions.
|
not-forward
|
www.wallstreet-online.de
|
https://www.wallstreet-online.de/nachricht/19045554-danone-strong-fy-2024-results-entering-the-next-chapter-of-renew-with-confidence
|
First up, we discuss the ongoing dance between Electronic Arts and football association FIFA. While EA has claimed it's considering a rebrand for its best-selling football series, FIFA has suggested it's considering licensing out its brand to additional parties.
|
forward
|
www.gamesindustry.biz
|
https://www.gamesindustry.biz/ea-and-fifa-usd1bn-branding-dance-podcast
|
SAN DIEGO, March 2, 2021 /PRNewswire/ -- Neurocrine Biosciences NBIX today announced that investigational drug luvadaxistat (NBI-1065844/TAK-831) did not meet its primary endpoint in the Phase II INTERACT study in adults with negative symptoms of schizophrenia, as measured by the change from baseline on the PANSS NSFS at Day 84. Luvadaxistat met secondary endpoints of cognitive assessment, which merit further clinical evaluation. The adverse event profiles for luvadaxistat were consistent with previous trials. Takeda Pharmaceutical Company Limited ("Takeda") granted an exclusive license to Neurocrine Biosciences for seven pipeline programs, including luvadaxistat, in June 2020.
|
not-forward
|
www.benzinga.com
|
https://www.benzinga.com/pressreleases/21/03/n19935103/neurocrine-biosciences-announces-top-line-results-from-phase-ii-interact-study-evaluating-luvadaxi
|
The Top 100 Global Innovators uses a complete comparative analysis of global invention data to assess the strength of every patented idea, using measures tied directly to their innovative power. The report analyzes data from the Derwent World Patents Index™ (DWPI™) and the Derwent Patents Citation Index™. Recipients of South Asia Innovation Awards (listed in alphabetical order): Nicholas Mason, Head of Intellectual Property markets, South Asia Pacific, Clarivate, said: "The winners of our South Asia Innovation Awards 2023 are transforming industries and creating a positive impact in society. South Asia is a populous region with great growth potential. We are committed to helping our customers in the region drive innovation by unlocking the full value of their intellectual property through our deep expertise, insights and solutions." "At UPL, we see innovation as a catalyst for driving real world impacts.
|
not-forward
|
green-reporter.com
|
https://green-reporter.com/clarivate-recognizes-most-innovative-companies-in-south-asia
|
That is why Moderna's recent announcement that it will not enforce the intellectual property rights of its COVID-19 vaccine may not mean much. Moderna can change its mind at any time, and it is also not the sole holder of the mRNA technology used in its vaccines. In fact, hundreds of patents, held by various entities, are related to the mRNA technology, meaning that even if Moderna does not enforce its patent, the legal risk remains because other companies, such as Pfizer, could.
|
not-forward
|
www.voanews.com
|
https://www.voanews.com/a/covid-19-pandemic_us-weighs-loosening-vaccine-patents-help-global-covid-fight/6205360.html
|
Under the terms of the agreement, TG Therapeutics will receive exclusive worldwide rights to develop and commercialize azer-cel in non-oncology indications, and in exchange, Precision will receive upfront and potential near-term economics valued at $17.5 million. The upfront payment of $7.5 million will consist of cash and the purchase of Precision common stock by TG Therapeutics at a 100% premium to the 30-day VWAP prior to purchase.
|
forward
|
www.benzinga.com
|
https://www.benzinga.com/pressreleases/24/01/g36552587/tg-therapeutics-announces-global-license-agreement-with-precision-biosciences-for-the-development-
|
Separately, it was announced earlier that the Norwegian Ministry of Petroleum and Energy granted four licences to MOL Norge on the Norwegian Continental Shelf at the 2016 APA (Award in Pre-Defined Areas) licensing round, including one with operatorship. MOL has been granted operatorship in an additional position in the Mandal High Area, one of MOL Norge's core areas in Norway. The partners in the new operated licence include Statoil and Petoro AS, the leading national oil and gas companies in Norway. MOL has also successfully joined three licenses operated by Aker BP.
|
not-forward
|
www.worldoil.com
|
https://www.worldoil.com/news/2017/2/7/mol-group-expands-its-exploration-portfolio-in-hungary-and-norway
|
Saudi Aramco will have an exclusive license to the Shell brand at gas stations in Texas, most of the Mississippi Valley, the Southeast and the Mid-Atlantic region. Shell will own its brand in Florida, Louisiana and the Northeast.
|
forward
|
www.houstonchronicle.com
|
https://www.houstonchronicle.com/business/energy/article/Shell-and-Saudi-s-seek-to-split-apart-Motiva-6894616.php
|
She went on to rule that a range of licensing practices employed by the company caused anti-competitive harm, including its "no license, no chips" policy of supplying modem chips only on condition that mobile manufacturers agree to its license terms, charging unreasonably high royalty rates for standard essential patents (SEPs), and exclusive chip supply agreements. A permanent injunction was warranted, said the judge, and she recommended a number of remedies to address the concern that Qualcomm may repeat the infringements. Among these are a prohibition on Qualcomm making the supply of modem chips conditional on entering a license, a requirement to grant SEP licenses on fair, reasonable and non-discriminatory (FRAND) terms, a bar on Qualcomm entering exclusive chip supply agreements, and a requirement for the company to submit to FTC monitoring for seven years.
|
not-forward
|
www.jdsupra.com
|
https://www.jdsupra.com/legalnews/antitrust-in-focus-second-edition-54148
|
Prosonix' proprietary particle engineering technology enables it to design and engineer mono and combination drug particles that precisely meet the specific requirements for inhalation, delivering assured formulation performance using simple, cost-effective devices for a range of generic, super-generic and novel products. Prosonix' pipeline focuses on near- and long-term opportunities, and is further complemented by a select number of partnered respiratory programmes. The in-house pipeline includes: Additional partnered respiratory programmes include: Global Initiative for Asthma (GINA) Guidelines - Updated July 2014 Evohaler® Flixotide®, Flovent®, Seretide® and Serevent® are trademarks of the GlaxoSmithKline group of companies. Spiriva® is a trademark of Boehringer Ingelheim.
|
not-forward
|
www.prnewswire.co.uk
|
https://www.prnewswire.co.uk/news-releases/prosonix-marketing-authorisation-application-for-psx1001---a-generic-version-of-glaxosmithklines-flixotide-evohaler---under-assessment-in-eu-273527631.html
|
Rambus Inc. and Micron Technology, Inc. have signed a broad patent cross license agreement. Under the agreement, Micron gains the right to use any Rambus patent for the manufacture of specified integrated circuit products, including any memory integrated circuit products. Certain of these memory products will enjoy a perpetual, paid-up license after the end of the initial term. The agreement requires quarterly royalty payments to Rambus over the next seven years capped at $10 million per quarter, with a rolling twelve-month cap fixed at $40 million, or $280 million during the initial term. In addition, Micron will have the option to extend the initial term of this agreement for additional renewal periods. As part of this agreement, the two companies have settled all outstanding patent and antitrust claims, and the agreement covers both Micron and Elpida products. Other terms and details of the agreement are confidential.
|
not-forward
|
www.storagenewsletter.com
|
https://www.storagenewsletter.com/2013/12/16/micron-gains-right-to-use-any-rambus-patent
|
Technically, the Peloton Tread+ is a treadmill that's meant to do one thing: Play Peloton content. Unless you jailbreak your Peloton, you can't watch Netflix or listen to your own music, as you might with some of the fancier treadmills at the gym—at least, not without voiding the warranty. If a manufacturer changes the software of your device, well, it's their software. Generally speaking, it's good security hygiene to update your software to the latest version whenever they're made available. (This is true with Pelotons, too, which recently had two security issues .) So you can't legally modify the Tread+'s software and it's not a good idea to forgo updates. That means you can either ask for a refund or deal with it. At the end of the day, you're actually just licensing the hardware—even if you paid to own it.
|
not-forward
|
gizmodo.com
|
https://gizmodo.com/peloton-s-new-tread-problem-is-a-reminder-that-you-don-1847149583
|
Toys R Us lenders took over the retailer's intellectual property last year, after more than 100 parties were potentially interested in acquiring it. TRU Kids was the vehicle created to house the IP and keep the Toys R Us brand alive and profitable. Running the company as CEO is Richard Barry, former global chief merchandiser for Toys R Us.
|
not-forward
|
www.retaildive.com
|
https://www.retaildive.com/news/toys-r-us-candytopia-partner-for-experiential-pop-ups/563285
|
The government of Guyana has announced that it has reached an agreement with ExxonMobil to double the company's royalty payments on offshore oil recovered from the waters off the coast of the South American nation. The Ministry of Natural Resources says ExxonMobil will receive a royalty of 2 percent on gross earnings and 50 percent of profits. Production of 100,000 barrels per day is expected to start in 2020. The statement late Thursday also said that ExxonMobil would soon receive a production license along with partners Hess Guyana Exploration Ltd. and CNOOC Nexen.
|
forward
|
www.foxbusiness.com
|
http://www.foxbusiness.com/markets/2017/06/02/exxonmobil-agrees-to-double-oil-royalty-payments-to-guyana.html
|
It's clear Zynga is looking for other revenue streams and recently struck a big licensing deal with Hasbro to turn games like FarmVille, CityVille, and its other hit titles into real world products and toys.
|
not-forward
|
techcrunch.com
|
http://techcrunch.com/2012/02/14/zynga-earnings
|
Symantec has delayed its virtualised security system for Intel's vPro platform because of licensing issues around the Windows CE platform, the company said on Tuesday. The delay is the latest setback for vPro, a bundle of Intel technologies aimed at business users. Among vPro's capabilities are virtualisation — which is built into the Core chips used in vPro — and the ability for management tools to access features that are outside the control of the main operating system. The vPro brand, along with the Viiv consumer platform, was part of Intel's attempt to recreate the success of the Centrino mobile wireless platform for laptops. In July Intel said it will begin de-emphasising vPro and Viiv from next year, in favour of the better-known Core brand. Symantec's Virtual Security Solution (VSS) is designed to run on a virtual appliance outside the main OS, making it harder for users or attackers to get at.
|
not-forward
|
www.zdnet.com
|
http://www.zdnet.com/licensing-issues-delay-vpro-security-3039288692
|
"W Las Vegas, the latest hotel to come to life as part of our collaboration, will allow our guests to access a new luxury lifestyle experience recognized worldwide for its distinct personality, dynamic programming and elevated service culture."
|
forward
|
safariindia.com
|
https://safariindia.com/marriott-international-and-mgm-resorts-international-sign-agreement-to-launch-w-las-vegas-7345807
|
Zai Lab has a collaboration and license agreement with GSK for the development and commercialization of ZEJULA in mainland China, Hong Kong, and Macau. (ZEJULA supply for China is independently manufactured by Zai Lab.)
|
not-forward
|
www.thetechoutlook.com
|
https://www.thetechoutlook.com/press-release/zai-lab-to-present-two-new-phase-3-analyses-for-niraparib-in-ovarian-cancer-at-the-2023-esmo-gynaecological-cancers-congress
|
Neupogen (and now Zarxio) are prescribed mostly for low white-blood cell disorders, often caused by chemotherapy. It had been a billion-dollar blockbuster for Amgen, but its use has declined somewhat in recent years. (By the way, both products are temperature-controlled, requiring refrigerated storage and transportation .) The smallest-dose (300 mg) prefilled syringe will be sold at wholesale at around $275, compared to Amgen's $324. That 15% discount is less than the 30% or so that analysts have been predicting for biosimilar price savings, but the price-negotiation process is only just getting starting in the US. "Even small-molecule generics, when they first enter the market, are priced at 15-20% below the originator product," notes Larry Blandford, EVP and managing partner at Precision for Value, a New York marketing-consulting firm. "When additional small-molecule generics show up, the price drops 60% or more."
|
not-forward
|
www.pharmaceuticalcommerce.com
|
https://www.pharmaceuticalcommerce.com/view/sandoz-filgrastim-biosimilar-is-now-on-the-us-market
|
[1/2] State Bank of India (SBI) Chairman Rajnish Kumar is seen during a news conference in Mumbai, India, November 23, 2017. REUTERS/Danish Siddiqui Purchase Licensing Rights, opens new tab
|
not-forward
|
www.reuters.com
|
https://www.reuters.com/article/us-davos-meeting-state-bank-india/indias-sbi-expects-loan-demand-to-rise-with-government-spending-idUSKBN1FD2RE
|
Samsung and Apple have been in the courts and the headlines a lot since 2011 when Apple started proceedings about Samsung's alleged copycat products, said to be influenced by the iPhone and the iPad. Following the legal wrangling Apple has seemed to have continually reduced its reliance on Samsung components to manufacture its iDevices, even if they were once the best choice.
|
not-forward
|
hexus.net
|
https://hexus.net/business/news/legal/58073-samsung-apple-negotiating-cross-licensing-deals
|
When do record revenues, beating analyst earnings estimates, and generating a 35% jump in operating income result in a 5% drop in share price? The mobile industry's chipmaking and licensing leader Qualcomm can tell you firsthand: Follow up positive financials with a distressing outlook for the established mobile-device market. Not good news for Qualcomm, but its high-end manufacturers, such as Apple and BlackBerry with its new Z10 and Q10 offerings, could really feel the pain. Quarterly recap Qualcomm's fiscal Q1 was impressive by most measures, compared with last year's Q1 and sequentially, its own forecasts for the quarter, and analyst expectations. As CEO Dr. Paul Jacobs put it, "We are pleased to announce record quarterly revenues." Jacobs also let investors know Qualcomm was pleased to raise its guidance for the balance of its fiscal year.
|
forward
|
www.aol.com
|
https://www.aol.com/2013/04/26/qualcomms-ominous-warning
|
Telstra has also been focused on media offerings, last week reaching a multi-year deal with TiVo Corporation to gain access to its intellectual property (IP) on devices and applications after launching the second iteration of its Telstra TV media box in October.
|
not-forward
|
www.zdnet.com
|
https://www.zdnet.com/article/telstra-announces-a-league-broadcast-deal
|
A National Australia Bank (NAB) logo is pictured on an automated teller machine (ATM) in central Sydney September 12, 2014. REUTERS/David Gray/File Photo Purchase Licensing Rights, opens new tab
|
not-forward
|
www.reuters.com
|
https://www.reuters.com/article/australia-banks-apple-idINKCN10U04L?edition-redirect=in
|
Titan International Inc. has expanded its licensing agreement with Goodyear Tire & Rubber Co., and the new pact gives Titan the ability to distribute and manufacture more Goodyear-brand farm tires around the world. The license agreement allows Titan to distribute and sell Goodyear-brand farm tires in Europe, the Middle East, Africa, Russia and other Commonwealth of Independent States countries. It also allows Titan to manufacture such farm tires in parts of the licensed territory outside the European Union. In addition, Titan has purchased certain Goodyear molds and other assets currently located in Poland, Turkey and South Africa. "We are very excited to expand upon our existing licensing arrangements in North America and Latin America to now include licensing of the Goodyear-brand farm tires in these additional, important agricultural regions," says Maurice Taylor, Chairman and CEO of Titan.
|
forward
|
www.moderntiredealer.com
|
https://www.moderntiredealer.com/articles/17424-titan-is-back-in-the-game-thanks-to-latest-goodyear-agreement
|
[1/2] Dieter Zetsche, Chairman of the Board for Daimler AG and Head of Mercedes-Benz, sits in the 2016 Mercedes-AMG SLC 43 at the North American International Auto Show in Detroit, Michigan, January 11, 2016. REUTERS/Gary Cameron/File Photo Purchase Licensing Rights, opens new tab
|
not-forward
|
www.reuters.com
|
https://www.reuters.com/article/us-daimler-electric-tesla-idUSKCN10Z15N
|
Call of Duty: Infinite Warfare 's Sabotage DLC is now available to download on Xbox One and PC, Activision has announced. Having been available on PlayStation 4 since January due to Sony's timed exclusivity agreement with the publisher, it wasn't entirely clear when the new content was going to drop for the other two platforms, although most had generally expected to patiently twiddle their thumbs for around an additional month, similarly to Microsoft's previous deal.
|
not-forward
|
wegotthiscovered.com
|
https://wegotthiscovered.com/gaming/call-duty-infinite-warfares-sabotage-dlc-now-available-xbox-one-pc
|
Arista Networks climbed more than 7% despite the company's loss in a court ruling over a patent dispute against Cisco Systems ( CSCO 1.69% ). Cisco had alleged that Arista had violated Cisco's patents, and a judge at the International Trade Commission found in favor of Cisco on two of the five patents at issue in the case. Yet even with the adverse ruling potentially leading to a negative adjudication expected within the next four months or so, Arista investors seemed confident that the company could find a way to get around any intellectual property issues and release new software that will avoid any controversy going forward. In particular, Arista has done a good job of assuring customers that there won't be any disruption in their services regardless of the eventual outcome of the case, and investors have faith that the company therefore won't see a big drop in revenue as a result.
|
not-forward
|
www.fool.com
|
https://www.fool.com/investing/general/2016/02/03/why-arista-networks-energizer-holdings-and-angies.aspx
|
Men walk past an electronic board at the Tel Aviv Stock Exchange, in Tel Aviv, Israel November 4, 2020. REUTERS/Amir Cohen Purchase Licensing Rights, opens new tab
|
not-forward
|
www.reuters.com
|
https://www.reuters.com/markets/israel-eyes-shift-monday-friday-trading-win-over-msci-regulator-2024-01-17
|
BioWare's developers are hard at work on Mass Effect, a brand new BioWare-created intellectual property, and an Xbox 360 exclusive, to be published by Microsoft. Mass Effect is an epic science-fiction role-playing game set in a spectacular new vision of the future. BioWare's new studio in Austin, Texas, has begun work on a new massively multiplayer online game, marking BioWare's entry into the MMO space. In 2006, BioWare formed a new group to develop games for handheld platforms, beginning with the Nintendo DS. Jade Empire, BioWare's first game based on a BioWare-created intellectual property, was released for Xbox in April 2005 to critical and commercial success, with a PC version scheduled for release early 2007, to be published by 2K Games.
|
forward
|
www.gamesindustry.biz
|
https://www.gamesindustry.biz/bioware-to-integrate-ageia-physx-technology-into-next-generation-eclipse-engine
|
The procurement is a key milestone of the Project BioShield (PBS) contract between MediWound and BARDA which was signed in September 2015 with procurement initiated in January 2020. Under the PBS contract, BARDA provides funds and support for the advancement of the development and manufacturing of NexoBrid, as well as the procurement of NexoBrid as a medical countermeasure for mass casualty emergencies involving thermal burns. In May 2019, Vericel entered into exclusive license and supply agreements with MediWound to commercialize NexoBrid in North America. As part of the license agreement, Vericel and MediWound will equally split gross profits generated by BARDA's initial $16.5 million procurement. In October 2019, MediWound initiated the NEXT protocol, which is supported and funded by BARDA and enables the continued clinical use of NexoBrid for U.S. patients during the preparation and review of the NexoBrid BLA.
|
not-forward
|
markets.businessinsider.com
|
https://markets.businessinsider.com/news/stocks/mediwound-and-vericel-announce-acceptance-of-the-first-delivery-of-nexobrid-to-barda-for-emergency-response-preparedness-1029530810
|
Inside is the cal.1142, a significantly revamped Lemania 2310 that VC now produces. The rights to produce the Lemania 2310 came to Richemont, VC's parent company, via its acquisition of Roger Dubuis, which had acquired the intellectual property for several Lemania movements in the mid-2000s.
|
not-forward
|
watchesbysjx.com
|
https://watchesbysjx.com/2015/08/introducing-the-vacheron-constantin-historiques-cornes-de-vache-1955-chronograph-with-an-upgraded-in-house-lemania-with-pricing.html
|
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that in response to the rapid increase in COVID-19 cases in India, the company is providing its voluntary licensing partners with technical assistance, support for the addition of new local manufacturing facilities and the donation of active pharmaceutical ingredient (API) to rapidly scale up production of remdesivir. Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory confirmed COVID-19 in adults and children hospitalized with severe disease. In addition to providing support to its licensees to expand their local manufacturing capacity, Gilead will also donate at least 450,000 vials of Veklury® (remdesivir) to help address the immediate needs of Indian patients.
|
forward
|
www.gesundheit-adhoc.de
|
https://www.gesundheit-adhoc.de/gilead-sciences-announces-steps-to-expand-availability-of-remdesivir-in-india
|
Marks last week told the Fairfax Media company that he chose to end talks over sublicensing the final year of Seven's rights after an a "very fair" offer for the 2019 Australian Open was rejected. Nine's offer reportedly represented an A$10m premium on Seven's current deal with Tennis Australia, which is worth about A$40m per year.
|
not-forward
|
media.sportbusiness.com
|
https://media.sportbusiness.com/news/nine-returns-to-the-court-for-extended-australian-open-deal
|
In March 2018, Asahi Kasei Pharma Corporation and RaQualia Pharma Inc. entered into a license agreement for a novel P2X7 receptor antagonist. Under this agreement, Asahi Kasei Pharma obtained exclusive rights for worldwide development, manufacture, and sale of P2X7 receptor antagonist, while RaQualia Pharma will receive a lump-sum payment as well as milestone payments corresponding to stages of development, and royalty payments in proportion to sales amounts. The P2X7 antagonist is AKP-23494954/RQ-00466479. In 2016, CONBA Pharmaceutical revised the synthetic route for EVT401. Furthermore, additional pre-clinical pharmacokinetics and safety studies are being conducted in order to meet the requirements of the China Food and Drug Administration prior to seeking approval for further clinical studies. In 2012, Evotec AG granted exclusive rights for EVT401 in China to CONBA Pharmaceutical.
|
forward
|
www.coherentmarketinsights.com
|
https://www.coherentmarketinsights.com/press-release/p2x7-receptor-antagonists-market-to-surpass-us-1352-million-threshold-by-2026-1373
|
Then came OrganiGram Holdings ( OGI -3.16% ), the newest Canadian cannabis stock to cut production. On Monday, Nov. 25, New Brunswick-based OrganiGram announced that it would be halting Phase 4C construction at its Moncton facility. Phase 4C was expected to increase OrganiGram's output by 24,000 kilos at full capacity. Assuming the company achieves full licensing for Phase 4B, it'll be operating with an annual run rate of 89,000 kilos, as opposed to the 113,000 kilos at full capacity that management has touted.
|
forward
|
www.fool.com
|
https://www.fool.com/investing/2019/11/29/another-day-another-marijuana-production-cut-in-ca.aspx
|
For its part, Salesforce questions whether SAP can transition its business model to software-as-a-service for CRM. "They have a licensing model where they expect companies to pay up front. You can't take that revenue stream and collapse it overnight into recurring revenue," said Phill Robinson, Salesforce's senior vice president of marketing. "I don't see SAP being any more successful making that adjustment than Siebel has been."
|
not-forward
|
www.crn.com
|
https://www.crn.com/news/applications-os/163701423/sap-readies-on-demand-crm
|
As a result of the new guidelines set out by the Cyberspace Administration of China (CAC), record labels are no longer allowed to issue exclusive licenses to music services. Previously, music services in China were able to secure exclusive deals with record labels which meant that these services could then sub-license to other platforms in the region for an additional licensing fee. The policy builds on China's State Administration for Market Regulation's (CSAMR) move to reduce Tencent Music's market dominance by requiring the company to end its exclusive label licensing deals. Tencent Music (home to QQ Music, Kugou Music and Kuwo Music) is still permitted to keep its exclusive deals with independent artists, with a time limit of three years for such agreements.
|
not-forward
|
www.midiaresearch.com
|
https://www.midiaresearch.com/blog/axing-exclusive-music-licenses-in-china-will-drive-new-local-music-cultures
|
Microsoft and Samsung Electronics Co Ltd have settled a contract dispute over patent royalties, though terms of the settlement are confidential, Microsoft said in a statement on Monday.
|
not-forward
|
www.itvoice.in
|
https://www.itvoice.in/microsoft-samsung-settle-contract-dispute-over-patents
|
FILE PHOTO: A pedestrian looks at his phone as he walks past a logo for Australia's Westpac Banking Corp located outside a branch in central Sydney, Australia, November 5, 2018. REUTERS/David Gray Purchase Licensing Rights, opens new tab
|
not-forward
|
www.reuters.com
|
https://www.reuters.com/article/us-westpac-divestiture/westpac-to-sell-lenders-mortgage-insurance-business-to-arch-capital-idUSKBN2BA02L
|
VMware announced plans in July to license and price its virtualization technology based on the amount of virtual RAM assigned to a virtual machine (VM) with vSphere 5.0. In early August, VMware announced it would bend a bit ; though the new licensing scheme basically would remain the same, it dropped the pricing in certain cases. "Even after modifying the vSphere 5.0 memory entitlements (on August 3), the fundamental tax on memory still exists, which is an anathema to customers, and VMware is still receiving colorful feedback from their customers," said Jeff Woolsey, Principal Program Manager Lead for Windows Server Virtualization, in Microsoft's latest post. Woolsey reiterated that Microsoft isn't planning to make similar licensing or pricing changes around VM memory, cores or replication. "Per VM taxes are what virtualization vendors do, not strategic cloud providers," Woolsey blogged. He also noted that the amount of memory in a Hypver-V VM in Windows 8 Server "is going to go up. Way up."
|
forward
|
www.zdnet.com
|
http://www.zdnet.com/article/microsoft-keeps-the-pressure-on-vmware-around-its-latest-virtualization-licensing-changes
|
Last Friday, shares in Woburn, Massachusetts headquartered Skyworks Solutions Inc. gained 0.33%, closing the session at $78.21 with a total trading volume of 2.18 million shares. The stock has advanced 0.53% in the last one month, 8.11% over the previous three months, and 3.48% on an YTD basis. The Company's shares are trading 3.23% above their 50-day moving average and 12.19% above their 200-day moving average. Furthermore, shares of Skyworks Solutions, which together with its subsidiaries, designs, develops, manufactures, and markets proprietary semiconductor products, including intellectual property worldwide, have an RSI of 57.35.
|
not-forward
|
www.prnewswire.com
|
https://www.prnewswire.com/news-releases/semiconductor-stocks-on-investors-radar----taiwan-semiconductor-manufacturing-marvell-technology-skyworks-solutions-and-analog-devices-602220965.html
|
The big question is whether all the merchandise currently offered by Tesco via the Direct operation will automatically migrate over to the Tesco website; rumour has it that may not be the case. I'm hearing instances of FOB orders placed months ago being cancelled with immediate effect, and even the suggestion that if suppliers don't accept the cancellation, there is the implication (threat, some might say…) that Tesco will simply trash the price. If that is true, it strikes me as a relatively dangerous game to play on any number of levels. And while it will be a nuisance to many small online retailers and some suppliers, it surely opens up opportunities for other marketplaces such as OnBuy and online operators like Groupon.
|
forward
|
toyworldmag.co.uk
|
https://toyworldmag.co.uk/say-zeitgeist-one-more-timeits-the-vegas-blog
|
Sonos, a 1,500-person company, sued Google on Jan. 7 for allegedly infringing five patents covering multi-room audio technology. Spence said Google's dominance enabled it to violate the speaker company's intellectual property. He said that Google tries to prevent customers from using its voice assistants alongside another company's on Sonos speakers. While Amazon doesn't go that far, he said, it has used its power to "to subsidize the conquest" of the booming smart-speaker market, particularly by under-pricing its offerings.
|
not-forward
|
www.latimes.com
|
https://www.latimes.com/business/technology/story/2020-01-17/google-abuses-power-sonos-ceo-congress
|
One big concern that remains for MTN and other market players is that Icasa's auction could still be set aside as the result of litigation brought by Telkom that is challenging the way the regulator approached the licensing process. The high court in Pretoria is set to hear the merits of Telkom's arguments from 11-14 April.
|
forward
|
techcentral.co.za
|
https://techcentral.co.za/mtn-promises-60-5g-coverage-in-south-africa-by-2025/209024
|
Arm and Nvidia have both signalled that they expect the deal to obtain regulatory approval, with Nvidia's chief executive Jensen Huang insisting that Arm will be unaffected by the trade war because its intellectual property will still be British. "As soon as we explain the rationale of the transaction and our plans, the regulators around the world will realise that these are two complementary companies," Mr Huang said at Arm's developer conference earlier this month. "The two companies being complementary when combined will create new innovations, which is good for the market."
|
forward
|
www.telegraph.co.uk
|
https://www.telegraph.co.uk/technology/2020/10/21/huawei-seeks-curbs-nvidias-40bn-deal-buy-britains-arm
|
The KRAFT brand was allocated to the grocery business, and consequently Kraft Foods Inc (parent entity of the snack foods business) changed its name to Mondelez International Inc. The registered owner of the KRAFT mark became Kraft Foods Group LLC, an IP holding company owned by Kraft Foods Group Inc. In Australia, a subsidiary of Kraft Foods Inc (Kraft Foods Limited, or KFL ) had since 1962 manufactured peanut butter at a plant in Port Melbourne, which it sold under the KRAFT brand. KRAFT peanut butter was for many years the clear market leader, with around 65% of sales in a total market worth $110 million annually (as at 2017). Pursuant to the restructure, KFL (including the Port Melbourne plant) was allocated to the snack foods business, and KFL became a subsidiary of Mondelez.
|
not-forward
|
www.mondaq.com
|
https://www.mondaq.com/australia/trademark/928658/kraft-v-bega-implications-for-trade-mark-licensing-in-australia
|
UPLIZNA® (inebilizumab-cdon) is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.
|
not-forward
|
investingnews.com
|
https://investingnews.com/solarvest-bioenergy-inc-granted-organic-omega-3-patent-in-japan
|
MCSN is also seeking for an order of a perpetual injunction restraining COSON and Chief Okoroji, their agents, assigns, servants, and anyone howsoever described from tampering with, licensing, collecting royalties on or dealing with musical works, sound recording and other ancillary works or rights in the repertoire of MCSN.
|
not-forward
|
tribuneonlineng.com
|
https://tribuneonlineng.com/mcsn-drags-coson-tony-okoroji-court
|
"We are happy to have renewed these important license agreements with Gray Television to continue to inform and entertain audiences across the country with CBS' leading programming," said Ray Hopkins, President, U.S. Networks Distribution, ViacomCBS. "This deal underscores our longstanding commitment to building successful affiliate partnerships that create shared and enduring value."
|
not-forward
|
apnews.com
|
https://apnews.com/press-release/pr-newswire/business-charlotte-new-york-meredith-corp-television-3176a0911ff6cd5e871c325a81feb452
|
Recently, Amgen's attempt to block Zarxio failed. A federal court in California interpreted a provision of the BPCIA not to require these disclosures and negotiations. Had Zarxio's manufacturer negotiated with Amgen, it could have received a temporary safe harbor against actions alleging infringement. However, the court held that not engaging in the disclosures was within the company's rights as well, finding the disclosure and negotiation requirements only applicable when a company chooses to engage in the negotiation process.
|
not-forward
|
www.theregreview.org
|
https://www.theregreview.org/2015/04/20/knofczynski-biosimilar-drug
|
"Today's tech-savvy consumers expect fast, superior service where and when they want it, and SpeedSolve helps companies meet these increasingly demanding customer needs," said Derek Walker, executive director of intellectual property technology licensing at AT&T. "SpeedSolve leverages communication channels to improve collaboration for a better user experience, and features smarter and streamlined customer relationship management strategies to achieve more cost-effective and efficient procedures." SpeedSolve monitors agent performance and productivity to improve processes, and also includes features for quality measurement, agent coaching, video-sharing and collaboration. The product is platform-agnostic, with applications available for smartphones and tablets. About Infosys Infosys partners with global enterprises to drive their innovation-led growth. That's why Forbes ranked Infosys 19 among the top 100 most innovative companies.
|
not-forward
|
www.prnewswire.co.uk
|
https://www.prnewswire.co.uk/news-releases/infosys-to-redefine-customer-service-with-speedsolve-a-next-generation-collaborative-product-169277256.html
|
"We have taken a close look at SyQuest's assets, particularly its intellectual property, and concluded that they can add value to our business and our shareholders," said Jodie Glore, Iomega's president and chief executive. Iomega is not purchasing SyQuest's liabilities. Warranty service and customer support obligations for products sold by SyQuest will remain the responsibility of SyQuest. Iomega also isn't purchasing SyQuest's subsidiary in Malaysia. SyQuest Malaysia's assets are being offered for sale separately, and Iomega said it will submit a bid for SyQuest Malaysia's equipment and inventory at "a price substantially below that being paid for the US assets." The deal also puts an end to the patent and trademark infringement lawsuits between the companies. The deal, set to close in the first quarter 1999, will have no effect on Iomega's fourth quarter 1998 financial results.
|
forward
|
www.wired.com
|
https://www.wired.com/1999/01/iomega-buys-bankrupt-syquest
|
– Greek State receives €1.234 billion upfront payment-Fraport Greece will further invest about €400 million for improving and expanding the airports' infrastructure by 2021- Focus on enhancing facilities, operational processes and the passenger experience- Single largest expansion of Fraport Group's international airport portfolio says CEO Schulte FRA/rap – Fraport Greece (73.4 percent owned by the Frankfurt based airport operator Fraport AG and 26.6 percent by Copelouzos Group) today commenced the 40-year concession for managing and developing 14 regional airports on the Greek mainland and popular holiday islands – a mamoth investment for the country's infrastructure and economically vital tourism sector.
|
forward
|
www.padovanews.it
|
http://www.padovanews.it/2017/04/11/fraport-greece-begins-40-year-concession-at-14-greek-regional-airports
|
With the new system, IBM could be poised to gain market share on Compaq and Hewlett-Packard, the current PC market leaders among consumers. IBM's use of its own chips comes at an ironic juncture because the company is currently phasing out these microprocessors. In September, National broke off a long-standing processor agreement with IBM: IBM will lose the right to make chips based around the Cyrix-National designs after the first of the year. IBM's semiconductor division has for years sought to land its chips inside of IBM's Aptiva machines, sources have said. Big Blue's PC division, however, has largely rejected them in favor of chips from Intel, AMD, and Cyrix. Some IBM consumer PCs have used the IBM-branded chip, but typically in computers sold to overseas markets. Nonetheless, IBM signed a technology licensing agreement with ST Microelectronics which could give IBM the opportunity to once again get back into the market for Intel clone chips.
|
forward
|
www.cnet.com
|
https://www.cnet.com/tech/tech-industry/ibm-599-pc-arrives
|
SCO's copyright claims and effort to seek licensing fees could slow the advance of Linux into corporate data centers, said George Weiss, an analyst for Gartner Inc. ''Companies are suddenly going to realize that they at least have to look at this issue closely,'' he said. But Linux supporters said most corporations viewed the SCO campaign as mainly a dispute between two companies, I.B.M. and SCO. ''The Linux momentum continues to be strong,'' said Stuart Cohen, chief executive of the Open Source Development Lab, a corporate consortium backed by Linux supporters, including I.B.M.
|
forward
|
www.nytimes.com
|
http://www.nytimes.com/2003/07/22/business/technology-sco-changes-tactics-in-dispute-over-linux.html
|
BHP, the world's biggest miner, said their joint venture Samarco had met licensing requirements to restart operations and production of iron ore pellets.
|
forward
|
www.thisismoney.co.uk
|
https://www.thisismoney.co.uk/money/markets/article-9085369/BHP-Vale-restart-production-Samarco.html
|
Xeris will also receive an upfront payment from Horizon and will be entitled to receive development, regulatory and sales-based milestones and royalties based on future sales if the commercial license option is exercised. The financial terms of the agreement have not yet been disclosed.
|
forward
|
finance.yahoo.com
|
https://finance.yahoo.com/news/xeris-xers-horizon-develop-ready-155603825.html
|
Two phase III studies of vadadustat in non-dialysis and dialysis kidney disease patients are underway. Monday's licensing deal is a nice win for Akebia because Fresenius is the largest dialysis provider in North America, serving approximately 40% of dialysis patients in the U.S. Here's how Akebia described the deal terms with Vifor: This agreement is structured as a profit-sharing arrangement between Akebia and Vifor Pharma. It is subject to approval of vadadustat by the FDA and inclusion of vadadustat in a bundled reimbursement model, upon which Akebia will receive a $20 million payment from Vifor Pharma. Akebia's revenue from the profit share and the milestone payment will be shared with Otsuka Pharmaceutical Co. Ltd., Akebia's U.S. collaborator. Akebia, in collaboration with Otsuka, plans to commercialize vadadustat in other dialysis organizations and centers and in the nondialysis market in the U.S.
|
forward
|
www.thestreet.com
|
https://www.thestreet.com/investing/stocks/akebia-secures-exclusive-access-to-u-s-dialysis-patients-with-vifor-fresenius-pact-14135989
|
Denosumab is a humanized mAb that inhibits the activator of nuclear factor kappa-B ligand (RANKL) to prevent development of osteoclasts, the cells that break down bone. The originator drug, Amgen's ( AMGN ) Prolia/Xgeva was approved in the US in 2010, recording $5.6 billion in global revenues last year.
|
not-forward
|
talkmarkets.com
|
https://talkmarkets.com/content/global-markets/week-in-review-suzhou-duality-out-licenses-two-adcs-to-biontech-in-17-billion-deal?post=391713
|
About Swell Swell emerged as the first online action sports retailer in the world in 1999 and today they continue their First In Surf tradition, redefining online retail and enhancing customer engagement levels by merging commerce and content. As the top online surf lifestyle destination for men and women, they look to influence and set the trends by partnering with brands and athletes that bring their customers innovative products, exclusive assortment, relevant content, and exceptional service. From bringing the very best from established surf brands such as Rusty, Volcom, RVCA, Hurley, and Quiksilver to hand selecting styles from upand-coming surf and lifestyle brands, they are carefully curating a selection of apparel, hard goods, footwear, wetsuits, boards, and more. About Rusty Rusty is a major wholesale supplier of surfwear apparel and accessories globally.
|
not-forward
|
licensinginternational.org
|
https://licensinginternational.org/news/universal-announces-buff-monster-x-minions-x-rusty-lost-in-paradise-capsule-collection
|
After the sale to Microsoft, Nokia's biggest business will be its unit selling wireless-network equipment to mobile-phone carriers, called Nokia Solutions and Networks. The unit has struggled amid intensifying competition from Sweden's Ericsson AB and China's Huawei Technologies Co. and ZTE Corp. The NSN division started a program in late 2011 to cut 17,000 jobs, or about 23 per cent of its total. Nokia said it will also keep its mapping and location services business, called Here, and its technology development and licensing division.
|
forward
|
www.theage.com.au
|
https://www.theage.com.au/business/microsoft-snaps-up-nokia-mobiles-and-ceo-20130903-2t2fl.html
|
As I discussed on the last conference call, on May 4, 2012, the Company executed a License Termination and Technology Transfer Agreement with Aeterna Zentaris, whereby the license agreement for KRX-0401 or perifosine was terminated, and in exchange for the transfer of the U.S. IND, development data, IP and contracts to Aeterna, Keryx will receive a royalty on future net sales if any, of perifosine in the U.S., Canada and Mexico. Zentaris has assumed all costs, related to the Perifosine program going forward. In terms of our financial guidance for the remainder of 2012, we expect the cash burn rate to remain well control at approximately $4 million per quarter due to the pending completion of the Zerenex Phase III clinical program under the SPA in the fourth quarter of this year, and the preparation for our expected NDA filings in the first quarter of 2013.
|
forward
|
www.thestreet.com
|
http://www.thestreet.com/story/11658505/3/keryx-biopharmaceuticals-ceo-discusses-q2-2012-results--earnings-call-transcript.html
|
Any forward-looking statement that we make in this release speaks only as of the date of such statement. Except as required by law, we do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this release. Contacts Media contact: Daniel Noonan, Tradeweb +1 646 767 4677 Investor contacts: Ashley Serrao, Tradeweb +1 646 430 6027 Sameer Murukutla, Tradeweb +1 646 767 4864
|
not-forward
|
aijourn.com
|
https://aijourn.com/tradeweb-announces-new-market-data-licensing-agreement-with-lseg
|
Papermaster didn't say directly that AMD will use ARM technology, but the company is open to using other instruction-set architectures, examples of which include ARM, MIPS and PowerPC. The new strategy comes amid sweeping changes in the computing landscape. Tablet and smartphone use has expanded dramatically, but x86 chips from AMD and Intel have yet to make their mark in those devices. Microsoft's Windows 8 OS for PCs and tablets, due later this year, will run on both x86 and ARM. The flexibility to include outside IP will allow AMD to adapt quickly to the fast-changing landscape, Papermaster said. Device makers want specialized chips for particular tasks, and AMD has a trove of IP in areas like graphics and display with which to build products. For example, AMD's graphics processor can be mixed with third-party IP for multimedia devices. "The dynamics of the chips are changing," Papermaster said.
|
forward
|
www.itworldcanada.com
|
https://www.itworldcanada.com/article/amd-move-could-mean-arm-in-future-chips/45915
|
Several companies and industry associations have also filed lawsuits challenging the price negotiation provisions of the IRA on various constitutional grounds. We will continue to follow the trends in this area as they develop. FTC Scrutiny Over Life Sciences Transactions In 2023, the Federal Trade Commission (FTC) continued its aggressive approach to reviewing life sciences acquisition transactions, notably challenging (1) Amgen Inc.'s $27.8 billion acquisition of Horizon Therapeutics plc and (2) Sanofi's exclusive license to Maze Therapeutic Inc.'s product candidate for the treatment of Pompe disease for up to $755 million. The FTC's argument in the Amgen case was unique as it focused on Amgen's theoretical use of bundled rebating to pressure insurers and pharmacy benefit managers into preferring two Horizon products that did not have any current competition on the market. Amgen was eventually allowed to move forward with the Horizon acquisition subject to entry into a consent decree with the FTC.
|
not-forward
|
www.morganlewis.com
|
https://www.morganlewis.com/blogs/asprescribed/2024/01/year-in-review-how-2023-events-affected-life-sciences-companies-and-transactions
|
So what: Most of you are probably scratching your head right now wondering what that sentence means. In simple terms, the certification Orexigen received states that Actavis ( AGN ) has taken steps to file an abbreviated new drug application for a generic version of Contrave, Orexigen's and Takeda's weight control management drug approved last year. In short, Actavis is challenging Orexigen's patents, which means Orexigen now needs to go on the defensive and protect its intellectual property rights.
|
not-forward
|
www.fool.com
|
https://www.fool.com/investing/general/2015/05/07/why-orexigen-therapeutics-inc-lost-a-sixth-of-its.aspx?source=iedfolrf0000001
|
With CRM 3.0, Microsoft also plans to inaugurate a Small Business Edition that would be optimized for easy installations and to run with Microsoft Small Business Server (SBS) 2003. This SKU, too, stands to bring easy information flow for Microsoft Business Contact Manager, a low-end personal information manager that's part of the Office family. "If you're stepping up from Office Business Contact Manager, you can pull that data forward easily," Wilson said.
|
forward
|
www.crn.com
|
https://www.crn.com/news/applications-os/165600246/microsoft-renames-crm-next-adds-hosted-licensing-option
|
In the decades since the release of the Macintosh, however, Apple has relinquished some of the control the company exhibited over its earliest personal computers: modern Apple computers are able to run the Windows operating system; Apple no longer engineers the processors in its desktop and laptop computers in-house; it is simpler to engineer macOS software than it was previously; and some Apple computers can be upgraded or modified by the home user with relative ease.
|
not-forward
|
www.vice.com
|
https://www.vice.com/en/article/the-iphone-is-an-ideal-machine-for-exerting-intellectual-property-control/?nb=1
|
The launch of Ocrevus will enable Roche to enter the lucrative MS market and will help Roche to diversify its existing drug portfolio, which is largely focused on immuno-oncology. Ocrevus is the first and only approved drug for the treatment of PPMS, addressing an important unmet need in MS. As such, the drug is already expected to see rapid uptake and reach blockbuster status, and ultimately pose fierce competition for the leading company in MS, Biogen. Biogen co-developed Ocrevus with Roche and will receive tiered royalty payments on US sales. However, the net effect of Ocrevus on sales for Biogen remains to be seen.
|
forward
|
www.pharmaceutical-technology.com
|
https://www.pharmaceutical-technology.com/comment/commentroches-ocrevus-expected-to-be-a-game-changer-for-the-multiple-sclerosis-market-5773916
|
1. Semglee, Insulin Glargine co-developed by Biocon and Mylan, is the first biosimilar from the partnered portfolio to be approved in the developed markets of EU and Australia. 2. Biocon also received Insulin Glargine approval in South Korea and biosimilar Trastuzumab approval in Turkey. 3. Biocon and Mylan agreed to accelerate the introduction of biosimilar Adalimumab in Europe through Mylan's in-licensing arrangement with Fujifilm Kyowa Kirin Biologics, to enable launch in EU, around market formation. 4. Biocon and Mylan have agreed to expand their long-standing collaboration to add two new next-generation biosimilar programs with Insulin Glargine 300 units/mL and Pertuzumab.
|
forward
|
www.businesstoday.in
|
https://www.businesstoday.in/sectors/pharma/biocon-q4-results-good-progress-on-biosimilars-though-margins-below-expectations/story/275718.html
|
I just think a foundry system gets spun out," said Daniel Newman, CEO of The Futurum Group. "For the record, whether it remains Intel foundry or spins out to be TSMC or some other iteration. The U.S. needs a U.S.-owned foundry for leading-edge chips that has full control of its intellectual property." "Looks like (Tan's) visit to the White House was a moment of progress. Could be a good sign for Intel's prospects," Newman added. Tan, who was born in Malaysia and raised in Singapore before attending college in the U.S., succeeded Gelsinger as the struggling chipmaker attempts to gain traction in an AI market dominated by NVIDIA Corp. and other upstarts. Intel has been burning through cash to build a foundry business for chip manufacturing. Since taking over Intel, Tan has told employees that the Silicon Valley giant has scrapped plans for manufacturing sites in Germany and Poland while pausing development of another one in Ohio.
|
not-forward
|
techstrong.it
|
https://techstrong.it/featured/trump-calls-intel-ceo-a-success-in-meeting-days-after-demanding-he-resign
|
They think it's all over … The football sim series that has graced the gaming charts every year since its launch in 1993 is about to face the final whistle, thanks to a licensing tussle with Fifa. Next year, Electronic Arts will be revealing its annoyingly named replacement, EA Sports FC, but for now, we get to run out on to this heavily branded pitch one last time.
|
forward
|
ca.movies.yahoo.com
|
https://ca.movies.yahoo.com/fifa-23-review-ea-final-150041185.html
|
Data presented at the American Society of Clinical Oncology Annual Meeting in June 2021 showed an overall survival of 81%. Both CARTITUDE-1 and the phase 2 CARTITUDE-2 are ongoing. Cilta-cel was developed by Legend Biotech, and in December 2017, Janssen Biotech entered into a collaboration agreement with Legend Biotech to develop and commercialize cilta-cel. Multiple myeloma is a cancer that develops in white blood cells. In patients with multiple myeloma, cancer cells accumulate in the bone marrow, crowding out healthy cells. Most patients are diagnosed because of symptoms such as bone fracture or pain, low red blood cell counts, high calcium levels, kidney problems or infections. The American Cancer Society predicts almost 35,00 new cases of multiple myeloma will be diagnosed in 2021 and there will be more than 12,000 deaths this year.
|
not-forward
|
www.managedhealthcareexecutive.com
|
https://www.managedhealthcareexecutive.com/view/fda-extends-review-of-janssen-s-car-t-therapy-for-multiple-myeloma
|
The television production joint venture responsible for "Big Brother" and "Deal or No Deal" is to continue for another three years after Southern Star and Dutch company Endemol clinched a new deal. Endemol Southern Star, based at Southern Star in Sydney, creates, develops and produces television programming for Australian and New Zealand broadcasters, as well as exporting its intellectual property to the rest of the world. Endemol is the creator of more than over 500 shows including "Extreme Makeover".
|
forward
|
www.smh.com.au
|
https://www.smh.com.au/business/southern-star-and-endemol-for-3-more-years-20061111-gdosv2.html
|
Lumoxiti received U.S. FDA approval in September 2018 and has been granted Orphan Drug Designation by the FDA and the EMA for the treatment of r/r HCL. AstraZeneca is the marketing authorization applicant for the EU filing. About Innate Pharma: Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma's broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
|
not-forward
|
apnews.com
|
https://apnews.com/press-release/globe-newswire/business-europe-corporate-news-marseille-western-europe-a9070e0eaff0970d344cfbc6eb745114
|
Google Google hoped that by allowing Java developers to code using the same API shortcuts with which they were already familiar, it would attract developers to work on Google's Android system. Google had initially approached the original owner of Java, Sun Microsystems, prior to Oracle acquiring them, to pay a licensing fee for the use of these APIs on its competing Android platform, but those negotiations broke down and Google moved forward with using the APIs without a license.
|
not-forward
|
www.mondaq.com
|
https://www.mondaq.com/unitedstates/copyright/698960/are-apis-no-longer-safe-to-use-when-creating-mobile-and-other-software-applications
|
I'm curious as to just how many Nintendo Switch 2 games will have the Game-Key Card as a purchase option and just how popular this will be. There have been various reactions on the Nintendo subreddit about this announcement. Some people are concerned about the current state of physical media. User TheChronoCross said, " Requires the cart, the server, an internet connection, and I'm willing to bet an account to be associated with the download. Any of those links interrupted due to licensing or depreciation and the cart is worthless ." However, user ValtsuMC notes that this is an overall positive for consumers, stating, " A key card would allow you to redownload and run the game while showing Nintendo that you've got a legitimate copy of the game ."
|
forward
|
screenrant.com
|
https://screenrant.com/nintendo-switch-2-game-key-cards
|
The unique, complementary fit of Pioneer's contiguous acreage will allow ExxonMobil to drill long, best-in-class laterals — up to four miles — which will result in fewer wells and a smaller surface footprint. The company also expects to enhance field digitalization and automation that will optimize production throughput and cost. Related Article: ExxonMobil Wins UK's first-ever Carbon Storage Licensing Round, Accelerating Net Zero Path The combination transforms ExxonMobil's upstream portfolio by increasing lower-cost-of-supply production, as well as short-cycle capital flexibility. The company expects a cost of supply of less than $35 per barrel from Pioneer's assets. By 2027, short-cycle barrels will comprise more than 40% of the total upstream volumes, positioning the company to more quickly respond to demand changes and increase capture of price and volume upside.
|
forward
|
esgnews.com
|
https://esgnews.com/amp/exxonmobil-announces-merger-with-pioneer-natural-resources-in-an-all-stock-transaction
|
We have enjoyed working with our Takeda colleagues to develop hepatic stellate cell-directed treatments to treat liver fibrosis and are delighted to expand the relationship further with this second collaboration," said Pete Lutwyche, Ph.D., president and chief executive officer, Genevant Sciences Corporation. "Building on our existing foundation with Genevant in liver fibrosis, we're excited to expand our work together to develop life-altering, nonviral gene therapies for specified rare liver diseases," said Bernard Allan, head of liver disease research at Takeda. "Genevant's expertise in the development of LNPs for clinical applications, coupled with Takeda's drug development capabilities and history in gastroenterology, gives us a great opportunity to develop new treatment options for patients with liver disorders."
|
forward
|
www.businesswire.com
|
https://www.businesswire.com/news/home/20210823005145/en/Genevant-Sciences-Announces-Global-Collaboration-and-License-Agreement-with-Takeda-to-Develop-Novel-Nonviral-Gene-Therapies-for-Up-to-Two-Rare-Liver-Diseases
|
ADVERSE REACTIONS The most common adverse reactions (≥5%) reported by patients treated with BELBUCA ® in the clinical trials were nausea, constipation, headache, vomiting, fatigue, dizziness, somnolence, diarrhea, dry mouth, and upper respiratory tract infection. Please see full Prescribing Information, including Boxed Warning and Medication Guide, for BELBUCA ®.
|
not-forward
|
www.prnewswire.com
|
https://www.prnewswire.com/news-releases/biodelivery-sciences-announces-granting-of-market-authorization-transfer-by-health-canada-for-belbuca-and-associated-milestone-payment-300517489.html
|
The Brazil deal is an exclusive license for the Cherokee brand with hypermarket operator Grupo Pao de Acucar, operator of the Extra hypermarket chain. The agreement covers product categories including apparel, footwear, and home.
|
not-forward
|
www.hometextilestoday.com
|
https://www.hometextilestoday.com/industry-news/brazil-latin-america-in-cherokee-crosshairs"
|
Even with all that, the company has more irons in the fire. Earlier this year it inked a nonexclusive licensing pact for its Ultragenyx HeLa manufacturing platform with Japanese pharma Daiichi Sankyo. It also licensed technology to drug giant Bayer for that company's work in developing drugs to treat hemophilia A.
|
not-forward
|
www.investors.com
|
https://www.investors.com/research/the-new-america/rare-stock-rolling-as-ultragenyx-drug-therapies-win-ultra-rare-challenges
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.